{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T15:20:36Z","timestamp":1790176836486,"version":"4.1.0"},"reference-count":61,"publisher":"Oxford University Press (OUP)","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2013,12]]},"DOI":"10.1093\/toxsci\/kft199","type":"journal-article","created":{"date-parts":[[2013,9,6]],"date-time":"2013-09-06T03:00:06Z","timestamp":1378436406000},"page":"487-499","source":"Crossref","is-referenced-by-count":36,"title":["Oxidizing Effects of Exogenous Stressors in Huntington\u2019s Disease Knock-in Striatal Cells\u2014Protective Effect of Cystamine and Creatine"],"prefix":"10.1093","volume":"136","author":[{"given":"M\u00e1rcio","family":"Ribeiro","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana C.","family":"Silva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joana","family":"Rodrigues","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luana","family":"Naia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A. Cristina","family":"Rego","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2013,9,5]]},"reference":[{"key":"key\n\t\t\t\t20170508161721_CIT0001","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1006\/exnr.2000.7525","article-title":"Mice with a partial deficiency of manganese superoxide dismutase show increased vulnerability to the mitochondrial toxins malonate, 3-nitropropionic acid, and MPTP","volume":"167","year":"(2001)","journal-title":"Exp. Neurol"},{"key":"key\n\t\t\t\t20170508161721_CIT0002","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1016\/j.neurobiolaging.2005.04.001","article-title":"The protective effects of cystamine in the R6\/2 Huntington\u2019s disease mouse involve mechanisms other than the inhibition of tissue transglutaminase","volume":"27","year":"(2006)","journal-title":"Neurobiol. Aging"},{"key":"key\n\t\t\t\t20170508161721_CIT0003","doi-asserted-by":"crossref","first-page":"6561","DOI":"10.1523\/JNEUROSCI.3353-11.2012","article-title":"Transglutaminase inhibition protects against oxidative stress-induced neuronal death downstream of pathological ERK activation","volume":"32","year":"(2012)","journal-title":"J. Neurosci"},{"key":"key\n\t\t\t\t20170508161721_CIT0004","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/0022-510X(92)90191-M","article-title":"Kynurenic acid concentrations are reduced in Huntington\u2019s disease cerebral cortex","volume":"108","year":"(1992)","journal-title":"J. Neurol. Sci"},{"key":"key\n\t\t\t\t20170508161721_CIT0005","first-page":"574","volume-title":"Methods of Enzymatic Analysis","year":"(1974)"},{"key":"key\n\t\t\t\t20170508161721_CIT0006","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.1523\/JNEUROSCI.16-04-01324.1996","article-title":"Superoxide production in rat hippocampal neurons: Selective imaging with hydroethidine","volume":"16","year":"(1996)","journal-title":"J. Neurosci"},{"key":"key\n\t\t\t\t20170508161721_CIT0007","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1002\/ana.410410514","article-title":"Oxidative damage and metabolic dysfunction in Huntington\u2019s disease: Selective vulnerability of the basal ganglia","volume":"41","year":"(1997)","journal-title":"Ann. Neurol"},{"key":"key\n\t\t\t\t20170508161721_CIT0008","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1111\/j.1750-3639.1999.tb00216.x","article-title":"Oxidative stress in Huntington\u2019s disease","volume":"9","year":"(1999)","journal-title":"Brain Pathol"},{"key":"key\n\t\t\t\t20170508161721_CIT0009","doi-asserted-by":"crossref","first-page":"11401","DOI":"10.1074\/jbc.273.19.11401","article-title":"Superoxide in apoptosis. Mitochondrial generation triggered by cytochrome c loss","volume":"273","year":"(1998)","journal-title":"J. Biol. Chem"},{"key":"key\n\t\t\t\t20170508161721_CIT0010","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/j.expneurol.2010.04.008","article-title":"Cystamine protects from 3-nitropropionic acid lesioning via induction of nf-e2 related factor 2 mediated transcription","volume":"224","year":"(2010)","journal-title":"Exp. Neurol"},{"key":"key\n\t\t\t\t20170508161721_CIT0011","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/j.bbrc.2007.05.093","article-title":"Increased oxidative damage and mitochondrial abnormalities in the peripheral blood of Huntington\u2019s disease patients","volume":"359","year":"(2007)","journal-title":"Biochem. Biophys. Res. Commun"},{"key":"key\n\t\t\t\t20170508161721_CIT0012","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1038\/embor.2011.65","article-title":"Tumour suppressor SIRT3 deacetylates and activates manganese superoxide dismutase to scavenge ROS","volume":"12","year":"(2011)","journal-title":"EMBO Rep"},{"key":"key\n\t\t\t\t20170508161721_CIT0013","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.neulet.2005.05.065","article-title":"Increased glutathione levels in cortical and striatal mitochondria of the R6\/2 Huntington\u2019s disease mouse model","volume":"386","year":"(2005)","journal-title":"Neurosci. Lett"},{"key":"key\n\t\t\t\t20170508161721_CIT0014","first-page":"217","article-title":"Nerve growth factor and striatal glutathione metabolism in a rat model of Huntington\u2019s disease","volume":"17","year":"(2000)","journal-title":"Restor. Neurol. Neurosci"},{"key":"key\n\t\t\t\t20170508161721_CIT0015","doi-asserted-by":"crossref","first-page":"8942","DOI":"10.1523\/JNEUROSCI.22-20-08942.2002","article-title":"Therapeutic effects of cystamine in a murine model of Huntington\u2019s disease","volume":"22","year":"(2002)","journal-title":"J. Neurosci"},{"key":"key\n\t\t\t\t20170508161721_CIT0016","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1097\/00005072-198701000-00002","article-title":"Morphologic and histochemical characteristics of a spared subset of striatal neurons in Huntington\u2019s disease","volume":"46","year":"(1987)","journal-title":"J. Neuropathol. Exp. Neurol"},{"key":"key\n\t\t\t\t20170508161721_CIT0017","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.expneurol.2010.01.002","article-title":"Mitochondrial-dependent apoptosis in Huntington\u2019s disease human cybrids","volume":"222","year":"(2010)","journal-title":"Exp. Neurol"},{"key":"key\n\t\t\t\t20170508161721_CIT0018","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1111\/j.1471-4159.2004.02726.x","article-title":"Cystamine increases L-cysteine levels in Huntington\u2019s disease transgenic mouse brain and in a PC12 model of polyglutamine aggregation","volume":"91","year":"(2004)","journal-title":"J. Neurochem"},{"key":"key\n\t\t\t\t20170508161721_CIT0019","doi-asserted-by":"crossref","first-page":"24460","DOI":"10.1074\/jbc.M112.382226","article-title":"trans-(-)-\u03b5-Viniferin increases mitochondrial sirtuin 3 (SIRT3), activates AMP-activated protein kinase (AMPK), and protects cells in models of Huntington Disease","volume":"287","year":"(2012)","journal-title":"J. Biol. Chem"},{"key":"key\n\t\t\t\t20170508161721_CIT0020","doi-asserted-by":"crossref","first-page":"1500","DOI":"10.1016\/j.freeradbiomed.2003.08.022","article-title":"Cytosolic and mitochondrial ROS in staurosporine-induced retinal cell apoptosis","volume":"35","year":"(2003)","journal-title":"Free Radic. Biol. Med"},{"key":"key\n\t\t\t\t20170508161721_CIT0021","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/j.bbrc.2006.01.136","article-title":"Oxidative stress promotes mutant huntingtin aggregation and mutant huntingtin-dependent cell death by mimicking proteasomal malfunction","volume":"342","year":"(2006)","journal-title":"Biochem. Biophys. Res. Commun"},{"key":"key\n\t\t\t\t20170508161721_CIT0022","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1212\/01.wnl.0000194318.74946.b6","article-title":"Creatine in Huntington disease is safe, tolerable, bioavailable in brain and reduces serum 8OH2\u2019dG","volume":"66","year":"(2006)","journal-title":"Neurology"},{"key":"key\n\t\t\t\t20170508161721_CIT0023","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/0003-2697(76)90326-2","article-title":"A fluorometric method for determination of oxidized and reduced glutathione in tissues","volume":"74","year":"(1976)","journal-title":"Anal. Biochem"},{"key":"key\n\t\t\t\t20170508161721_CIT0024","doi-asserted-by":"crossref","first-page":"42769","DOI":"10.1074\/jbc.M206911200","article-title":"Phosphorylation of Nrf2 at Ser-40 by protein kinase C regulates antioxidant response element-mediated transcription","volume":"277","year":"(2002)","journal-title":"J. Biol. Chem"},{"key":"key\n\t\t\t\t20170508161721_CIT0025","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1212\/WNL.50.5.1357","article-title":"1H NMR spectroscopy studies of Huntington\u2019s disease: Correlations with CAG repeat numbers","volume":"50","year":"(1998)","journal-title":"Neurology"},{"key":"key\n\t\t\t\t20170508161721_CIT0026","doi-asserted-by":"crossref","first-page":"e57932","DOI":"10.1371\/journal.pone.0057932","article-title":"Impaired mitochondrial dynamics and Nrf2 signaling contribute to compromised responses to oxidative stress in striatal cells expressing full-length mutant huntingtin","volume":"8","year":"(2013)","journal-title":"PLoS One"},{"key":"key\n\t\t\t\t20170508161721_CIT0027","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1016\/S1097-2765(00)80059-3","article-title":"Transglutaminase action imitates Huntington\u2019s disease: Selective polymerization of Huntingtin containing expanded polyglutamine","volume":"1","year":"(1998)","journal-title":"Mol. Cell"},{"key":"key\n\t\t\t\t20170508161721_CIT0028","doi-asserted-by":"crossref","first-page":"14580","DOI":"10.1073\/pnas.93.25.14580","article-title":"Peptides containing glutamine repeats as substrates for transglutaminase-catalyzed cross-linking: Relevance to diseases of the nervous system","volume":"93","year":"(1996)","journal-title":"Proc. Natl. Acad. Sci. U.S.A"},{"key":"key\n\t\t\t\t20170508161721_CIT0029","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.freeradbiomed.2011.09.030","article-title":"Measuring reactive oxygen and nitrogen species with fluorescent probes: Challenges and limitations","volume":"52","year":"(2012)","journal-title":"Free Radic. Biol. Med"},{"key":"key\n\t\t\t\t20170508161721_CIT0030","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1038\/nm0202-143","article-title":"Prolonged survival and decreased abnormal movements in transgenic model of Huntington disease, with administration of the transglutaminase inhibitor cystamine","volume":"8","year":"(2002)","journal-title":"Nat. Med"},{"key":"key\n\t\t\t\t20170508161721_CIT0031","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1385\/NMM:1:3:183","article-title":"Cytochrome C and caspase-9 expression in Huntington\u2019s disease","volume":"1","year":"(2002)","journal-title":"Neuromolecular Med"},{"key":"key\n\t\t\t\t20170508161721_CIT0032","doi-asserted-by":"crossref","first-page":"3919","DOI":"10.1093\/hmg\/ddq306","article-title":"Mitochondrial loss, dysfunction and altered dynamics in Huntington\u2019s disease","volume":"19","year":"(2010)","journal-title":"Hum. Mol. Genet"},{"key":"key\n\t\t\t\t20170508161721_CIT0033","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1006\/bbrc.2001.6164","article-title":"Direct antioxidant properties of creatine","volume":"290","year":"(2002)","journal-title":"Biochem. Biophys. Res. Commun"},{"key":"key\n\t\t\t\t20170508161721_CIT0034","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1021\/tx00026a012","article-title":"Evaluation of the probe 2\u2019,7\u2019-dichlorofluorescin as an indicator of reactive oxygen species formation and oxidative stress","volume":"5","year":"(1992)","journal-title":"Chem. Res. Toxicol"},{"key":"key\n\t\t\t\t20170508161721_CIT0035","doi-asserted-by":"crossref","first-page":"3825","DOI":"10.1074\/jbc.M205812200","article-title":"Cystamine inhibits caspase activity. Implications for the treatment of polyglutamine disorders","volume":"278","year":"(2003)","journal-title":"J. Biol. Chem"},{"key":"key\n\t\t\t\t20170508161721_CIT0036","doi-asserted-by":"crossref","first-page":"2015","DOI":"10.1074\/jbc.273.4.2015","article-title":"Validation of lucigenin (bis-N-methylacridinium) as a chemilumigenic probe for detecting superoxide anion radical production by enzymatic and cellular systems","volume":"273","year":"(1998)","journal-title":"J. Biol. Chem"},{"key":"key\n\t\t\t\t20170508161721_CIT0037","doi-asserted-by":"crossref","first-page":"5780","DOI":"10.1074\/jbc.M704704200","article-title":"Calcium homeostasis and mitochondrial dysfunction in striatal neurons of Huntington disease","volume":"283","year":"(2008)","journal-title":"J. Biol. Chem"},{"key":"key\n\t\t\t\t20170508161721_CIT0038","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1634\/stemcells.2007-0221","article-title":"Neural stem\/progenitor cells initiate the formation of cellular networks that provide neuroprotection by growth factor-modulated antioxidant expression","volume":"26","year":"(2008)","journal-title":"Stem Cells"},{"key":"key\n\t\t\t\t20170508161721_CIT0039","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1002\/jnr.22240","article-title":"NAD(P)H oxidase contributes to neurotoxicity in an excitotoxic\/prooxidant model of Huntington\u2019s disease in rats: Protective role of apocynin","volume":"88","year":"(2010)","journal-title":"J. Neurosci. Res"},{"key":"key\n\t\t\t\t20170508161721_CIT0040","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1523\/JNEUROSCI.18-01-00156.1998","article-title":"Neuroprotective effects of creatine and cyclocreatine in animal models of Huntington\u2019s disease","volume":"18","year":"(1998)","journal-title":"J. Neurosci"},{"key":"key\n\t\t\t\t20170508161721_CIT0041","doi-asserted-by":"crossref","first-page":"30773","DOI":"10.1074\/jbc.M504749200","article-title":"Mitochondrial respiration and ATP production are significantly impaired in striatal cells expressing mutant huntingtin","volume":"280","year":"(2005)","journal-title":"J. Biol. Chem"},{"key":"key\n\t\t\t\t20170508161721_CIT0042","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1074\/jbc.M111.309849","article-title":"Early alterations of brain cellular energy homeostasis in Huntington disease models","volume":"287","year":"(2012)","journal-title":"J. Biol. Chem"},{"key":"key\n\t\t\t\t20170508161721_CIT0043","doi-asserted-by":"crossref","first-page":"5421","DOI":"10.1046\/j.1432-1327.2000.01606.x","article-title":"Investigation of the Alamar Blue (resazurin) fluorescent dye for the assessment of mammalian cell cytotoxicity","volume":"267","year":"(2000)","journal-title":"Eur. J. Biochem"},{"key":"key\n\t\t\t\t20170508161721_CIT0044","first-page":"158","article-title":"Studies on the quantitative and qualitative characterization of erythrocyte glutathione peroxidase","volume":"70","year":"(1967)","journal-title":"J. Lab. Clin. Med"},{"key":"key\n\t\t\t\t20170508161721_CIT0045","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1023\/B:NERE.0000018843.83770.4b","article-title":"Increased formation of reactive oxygen species, but no changes in glutathione peroxidase activity, in striata of mice transgenic for the Huntington\u2019s disease mutation","volume":"29","year":"(2004)","journal-title":"Neurochem. Res"},{"key":"key\n\t\t\t\t20170508161721_CIT0046","doi-asserted-by":"crossref","first-page":"1857","DOI":"10.1016\/j.freeradbiomed.2012.09.004","article-title":"Glutathione redox cycle dysregulation in Huntington\u2019s disease knock-in striatal cells","volume":"53","year":"(2012)","journal-title":"Free Radic. Biol. Med"},{"key":"key\n\t\t\t\t20170508161721_CIT0047","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1038\/nprot.2008.56","article-title":"The selective detection of mitochondrial superoxide by live cell imaging","volume":"3","year":"(2008)","journal-title":"Nat. Protoc"},{"key":"key\n\t\t\t\t20170508161721_CIT0047a","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1016\/j.neuint.2011.04.009","article-title":"FK506 ameliorates cell death features in Huntington\u2019s disease striatal cell models","volume":"59","year":"(2011)","journal-title":"Neurochem Int"},{"key":"key\n\t\t\t\t20170508161721_CIT0048","first-page":"e4fbca54a2028b","article-title":"Protection by glia-conditioned medium in a cell model of Huntington disease","volume":"4","year":"(2012)","journal-title":"PLoS Curr"},{"key":"key\n\t\t\t\t20170508161721_CIT0049","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1023\/A:1010911417383","article-title":"Comparative analysis of superoxide dismutase activity between acute pharmacological models and a transgenic mouse model of Huntington\u2019s disease","volume":"26","year":"(2001)","journal-title":"Neurochem. Res"},{"key":"key\n\t\t\t\t20170508161721_CIT0050","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1016\/j.freeradbiomed.2008.05.014","article-title":"Proteomic and oxidative stress analysis in human brain samples of Huntington disease","volume":"45","year":"(2008)","journal-title":"Free Radic. Biol. Med"},{"key":"key\n\t\t\t\t20170508161721_CIT0051","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1111\/j.1471-4159.2005.03070.x","article-title":"Tryptophan metabolism and oxidative stress in patients with Huntington\u2019s disease","volume":"93","year":"(2005)","journal-title":"J. Neurochem"},{"key":"key\n\t\t\t\t20170508161721_CIT0052","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/0006-291X(86)90008-2","article-title":"Staurosporine, a potent inhibitor of phospholipid\/Ca++dependent protein kinase","volume":"135","year":"(1986)","journal-title":"Biochem. Biophys. Res. Commun"},{"key":"key\n\t\t\t\t20170508161721_CIT0053","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1016\/0092-8674(93)90585-E","article-title":"A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington\u2019s disease chromosomes","volume":"72","author":"The Huntington\u2019s Disease Collaborative Research Group","year":"(1993)","journal-title":"Cell"},{"key":"key\n\t\t\t\t20170508161721_CIT0054","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1111\/j.1471-4159.2006.04323.x","article-title":"Neurochemical changes in Huntington R6\/2 mouse striatum detected by in vivo 1H NMR spectroscopy","volume":"100","year":"(2007)","journal-title":"J. Neurochem"},{"key":"key\n\t\t\t\t20170508161721_CIT0055","doi-asserted-by":"crossref","first-page":"2799","DOI":"10.1093\/hmg\/9.19.2799","article-title":"Dominant phenotypes produced by the HD mutation in STHdh(Q111) striatal cells","volume":"9","year":"(2000)","journal-title":"Hum. Mol. Genet"},{"key":"key\n\t\t\t\t20170508161721_CIT0056","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1111\/j.1471-4159.2006.03724.x","article-title":"Transcranial magnetic stimulation attenuates cell loss and oxidative damage in the striatum induced in the 3-nitropropionic model of Huntington\u2019s disease","volume":"97","year":"(2006)","journal-title":"J. Neurochem"},{"key":"key\n\t\t\t\t20170508161721_CIT0057","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1111\/j.1471-4159.1979.tb11708.x","article-title":"Formation of a supplemental long time-constant reservoir of high energy phosphate by brain in vivo and in vitro and its reversible depletion by potassium depolarization","volume":"33","year":"(1979)","journal-title":"J. Neurochem"},{"key":"key\n\t\t\t\t20170508161721_CIT0058","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.1111\/j.1471-4159.2009.06074.x","article-title":"Combination therapy with coenzyme Q10 and creatine produces additive neuroprotective effects in models of Parkinson\u2019s and Huntington\u2019s diseases","volume":"109","year":"(2009)","journal-title":"J. Neurochem"},{"key":"key\n\t\t\t\t20170508161721_CIT0059","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1126\/science.1072221","article-title":"Mediation of poly(ADP-ribose) polymerase-1-dependent cell death by apoptosis-inducing factor","volume":"297","year":"(2002)","journal-title":"Science"},{"key":"key\n\t\t\t\t20170508161721_CIT0060","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/0022-510X(80)90028-3","article-title":"Metabolic impairment and membrane abnormality in red cells from Huntington\u2019s disease","volume":"47","year":"(1980)","journal-title":"J. Neurol. Sci"}],"container-title":["Toxicological Sciences"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/toxsci\/article-pdf\/136\/2\/487\/11011480\/kft199.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,17]],"date-time":"2024-05-17T17:23:51Z","timestamp":1715966631000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/toxsci\/article-lookup\/doi\/10.1093\/toxsci\/kft199"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,9,5]]},"references-count":61,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2013,9,5]]},"published-print":{"date-parts":[[2013,12]]}},"URL":"https:\/\/doi.org\/10.1093\/toxsci\/kft199","relation":{},"ISSN":["1096-6080","1096-0929"],"issn-type":[{"value":"1096-6080","type":"print"},{"value":"1096-0929","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,9,5]]}}}